Answers are grounded in this paper and cite their sources.
Therapeutic immunization with dendritic cells was safe and successful in raising antiviral cellular immune responses, including effector CD8(+) T cells with virus inhibitory activity. The stimulation of those potent immunological and antiviral effects, which have been associated with control of HIV-1, underscores the potential of dendritic cell vaccination in the treatment of HIV-1. The incomplete nature of the response in some patients helped to identify potential targets for future improvement, that is increasing antigenic spectrum and enhancing T-cell response.
No takes yet. Share an insight, caveat, or question.
Gulck et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: